Norovirus recombination in ORF1/ORF2 overlap.(RESEARCH) From: Emerging Infectious Diseases | Date: July 1, 2005| Author: Bull, Rowena A.; Clancy, Leighton E.; Hansman, Grant S.; Rawlinson, William D.; Tanaka, Mark M.; White, Peter A. | COPYRIGHT 2005 U.S. National Center for Infectious Diseases. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group.Copyright information

Norovirus (NoV) genogroups I and II (GI and GII) are now recognized as the predominant worldwide cause of outbreaks of acute gastroenteritis in humans. Three recombinant NoV GII isolates were identified and characterized, 2 of which are unrelated to any previously published recombinant NoV. Using data from the current study, published sequences, database searches, and molecular techniques, we identified 23 recombinant NoV GII and 1 recombinant NoV GI isolates. Analysis of the genet...

Related newspaper, magazine, and journal articles from HighBeam Research

	Norovirus recombination in ORF1/ORF2 overlap.(RESEARCH) Emerging Infectious Diseases ; Norovirus (NoV) genogroups I and II (GI and GII) are now recognized as the predominant worldwide cause of outbreaks of acute gastroenteritis in humans. Three recombinant NoV GII isolates were identified and characterized, 2 of which are unrelated to any previously published recombinant NoV. Using
	Characterization and subcellular compartmentation of recombinant 4-hydroxyphenylpyruvate dioxygenase from Arabidopsis in transgenic tobacco Plant Physiology ; Characterization and Subcellular Compartmentation of Recombinant 4-Hydroxyphenylpyruvate Dioxygenase from Arabidopsis in Transgenic Tobacco1 4-Hydroxyphenylpyruvate dioxygenase (4HPPD) catalyzes the formation of homogentisate (2,5-dihydroxyphenylacetate) from p-hydroxyphenylpyruvate and molecular
	Treating Traumatic Bleeding in a Combat Setting: Possible Role of Recombinant Activated Factor VII Military Medicine ; Introduction Recombinant activated factor VIl (rFVlIa) has been shown to be an effective treatment for bleeding episodes in a variety of coagulation and platelet disorders. The use of rFVIIa in trauma among patients without preexisting coagulopathy has not been approved by the Food and Drug
	Production of recombinant collagen for biomedical devices Biopharm ; Newly discovered collagens could be of major interest to the pharmaceutical industry. Considering the risks of using collagen from animal sources, recombinant production represents a valuable alternative. Several reliable systems can produce recombinant collagen, from traditional E. coli expression
	The industrial production costs of recombinant therapeutic proteins expressed in transgenic corn Biopharm ; ... et al., "Transgenics Go Commercial," BioPharm 11(7), 24-28 (1998). (8) Robert L. McKown, "Contract Manufacturing," Gen. Eng. News (1 October 1998). (9) Michael W. Glacken, "Economic Analysis of a Process to Produce Recombinant Protein from Transgenic Plants ...
	Bone Marrow Dosimetry and Safety of High ^sup 131^I Activities Given After Recombinant Human Thyroid-Stimulating Hormone to Treat Metastatic Differentiated Thyroid Cancer The Journal of Nuclear Medicine ; Recombinant human thyroid-stimulating hormone (rhTSH) recently was introduced as a radioiodine administration adjunct that avoids levothyroxine (LT-4) withdrawal and resultant hypothyroidism. The pharmacokinetics of ^sup 131^I after rhTSH administration are known to differ from those after LT-4
	Imaging of Tumor Angiogenesis Using ^sup 99m^Tc-Labeled Human Recombinant Anti-ED-B Fibronectin Antibody Fragments The Journal of Nuclear Medicine ; The aim of this study was to target the angiogenesis-associated extracellular matrix protein ED-B fibronectin for molecular imaging of solid tumors. Recombinant and chemically modified derivatives of the single-chain antibody fragment (scFv) L19, capable of being labeled with ^sup 99m^Tc, were
	Heterologous expression and characterization of recombinant phytochrome from the green alga Mougeotia scalaris Photochemistry and Photobiology ; Heterologous Expression and Characterization of Recombinant Phytochrome from the Green Alga Mougeotia scalaris* ABSTRACT The full-length apoprotein (124 kDa) and the chromophore-- binding N-terminal half (66 kDa) of the phytochrome of the unicellular green alga Mougeotia scalaris have been
	A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation The Journal of Nuclear Medicine ; Radioiodine remnant ablation (RRA) is frequently used after a thyroidectomy for differentiated thyroid carcinoma because it has been reported to reduce the number of local recurrences and to increase overall survival. Although the traditional method of preparation for RRA is thyroid hormone
	Dosimetry of Radioiodine Therapy in Patients with Nodular Goiter After Pretreatment with a Single, Low Dose of Recombinant Human Thyroid- Stimulating Hormone The Journal of Nuclear Medicine ; A single, low dose of recombinant human thyroid-stimulating hormone (rhTSH) doubles 24-h RAIU and causes a more homogeneous distribution of radioiodine on thyroid scintigrams of patients with nodular goiter. Pretreatment with rhTSH allows the therapeutic dose of ^sup 131^I to be reduced by 50%-60%

See all results.